Literature DB >> 29281858

Phosphatidylethanol Levels Among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence.

Kelly E Moore1, Olga J Santiago Rivera2, Bradley Anderson3, Jennifer E Johnson4, Judith A Hahn5, Megan E Kurth3, Madhavi K Reddy6, Yael C Schonbrun7, Michael D Stein3,8.   

Abstract

BACKGROUND: Phosphatidylethanol (PEth) is a direct biomarker for alcohol that is formed shortly after alcohol use and may remain detectable in blood for weeks after alcohol consumption. There is little research on alcohol use factors that influence PEth elimination, especially among women.
METHODS: Data were collected from 116 alcohol use-disordered women who were recently incarcerated. We used a 2-part model with logistic and linear components to examine whether alcohol consumption in the 2 weeks prior to incarceration and days since last alcoholic drink (operationalized as abstinence days prior to incarceration + days incarcerated) were associated with PEth detectability (>8 ng/ml) and level (ng/ml) in blood.
RESULTS: Participants reported drinking an average of 10 drinks per day in the 2 weeks prior to incarceration. Days since last drink was negatively associated with PEth level (odds ratio [OR] = 0.97, 95% confidence interval [CI] = 0.93; 0.99) and being PEth detectable (OR = 0.96, 95% CI = 0.91; 0.99). Quantity of alcohol consumed prior to jail admission was associated with PEth detection (OR = 1.08; 95% CI = 1.03; 1.16), but not PEth level.
CONCLUSIONS: Days since last alcoholic drink and drinks per day both influenced PEth detectability, but only days since last drink predicted PEth level among a large sample of women with alcohol use disorder in the criminal justice system.
Copyright © 2017 by the Research Society on Alcoholism.

Entities:  

Keywords:  Alcohol; Elimination; Incarceration; Phosphatidylethanol; Women

Mesh:

Substances:

Year:  2018        PMID: 29281858      PMCID: PMC5832587          DOI: 10.1111/acer.13587

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  25 in total

1.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

2.  Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics.

Authors:  A Varga; P Hansson; G Johnson; C Alling
Journal:  Clin Chim Acta       Date:  2000-09       Impact factor: 3.786

3.  LC-MS/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens.

Authors:  Andrea Faller; Barbara Richter; Matthias Kluge; Patrick Koenig; Helmut K Seitz; Annette Thierauf; Heike Gnann; Michaela Winkler; Rainer Mattern; Gisela Skopp
Journal:  Anal Bioanal Chem       Date:  2011-07-09       Impact factor: 4.142

4.  Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa.

Authors:  Judith A Hahn; Loren M Dobkin; Bernard Mayanja; Nneka I Emenyonu; Isaac M Kigozi; Stephen Shiboski; David R Bangsberg; Heike Gnann; Wolfgang Weinmann; Friedrich M Wurst
Journal:  Alcohol Clin Exp Res       Date:  2011-12-07       Impact factor: 3.455

5.  Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days.

Authors:  Heike Gnann; Wolfgang Weinmann; Annette Thierauf
Journal:  Alcohol Clin Exp Res       Date:  2012-03-28       Impact factor: 3.455

6.  Reliability and validity of 6-month timeline reports of cocaine and heroin use in a methadone population.

Authors:  R N Ehrman; S J Robbins
Journal:  J Consult Clin Psychol       Date:  1994-08

7.  Randomized controlled pilot study of cognitive-behavioral therapy in a sample of incarcerated women with substance use disorder and PTSD.

Authors:  Caron Zlotnick; Jennifer Johnson; Lisa M Najavits
Journal:  Behav Ther       Date:  2008-10-31

8.  Phosphatidylethanol Levels Are Elevated and Correlate Strongly with AUDIT Scores in Young Adult Binge Drinkers.

Authors:  Mariann R Piano; Stephanie Tiwari; Lauren Nevoral; Shane A Phillips
Journal:  Alcohol Alcohol       Date:  2015-06-07       Impact factor: 2.826

9.  A pilot study of group interpersonal psychotherapy for depression in substance-abusing female prisoners.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Subst Abuse Treat       Date:  2007-07-13

10.  Comparison of self-reported alcohol use with the alcohol biomarker phosphatidylethanol among young people in northern Tanzania.

Authors:  Joel M Francis; Helen A Weiss; Anders Helander; Saidi H Kapiga; John Changalucha; Heiner Grosskurth
Journal:  Drug Alcohol Depend       Date:  2015-10-01       Impact factor: 4.492

View more
  1 in total

1.  Reduction in Drinking was Associated With Improved Clinical Outcomes in Women With HIV Infection and Unhealthy Alcohol Use: Results From a Randomized Clinical Trial of Oral Naltrexone Versus Placebo.

Authors:  Robert L Cook; Zhi Zhou; Maria Jose Miguez; Clery Quiros; Luis Espinoza; John E Lewis; Babette Brumback; Kendall Bryant
Journal:  Alcohol Clin Exp Res       Date:  2019-07-10       Impact factor: 3.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.